Key Insights

Highlights

Treatment Research

2 treatments under study, led by Optokinetic Stimulation Through Virtual Reality

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Enrolling By Invitation1
Unknown1

Clinical Trials (2)

Research Network

Common Treatments

  • Optokinetic Stimulation Through Virtual Reality1
  • Cefazolin1

Active Sponsors

  • Asan Medical Center1
  • Universitair Ziekenhuis Brussel1

Top Investigators

Related Conditions

  • Pancreatoduodenectomy1
  • Infectious Complications1

Activity Timeline